In an example of the close collaboration between scientists working in different areas of medical research, we share how a research study hitting the headlines this week built on research to understand CF lung infections.
In October, NICE’s independent committee will meet to discuss Orkambi, Symkevi and Kaftrio and make recommendations on whether these treatments should be available on the NHS for people with CF who are not currently taking a modulator therapy, but who could benefit from them in the future.
As we publish the findings from our second experience survey in paediatric CF care, Dr Jana Witt, Clinical Quality Improvement Manager at the Trust, recaps some of the key findings
Yvonne, 50, speaks to us about growing up with CF, her experience of Kaftrio, her newfound passion for stand-up comedy and her experience performing at Edinburgh Fringe last month.
To celebrate this year’s Organ Donation Week we speak to Ana, who recently celebrated three years since her lung transplant and took part in the British Transplant Games
